Global Femoral Stems Market 2022-2026

Description

List of Tables

Technavio has been monitoring the femoral stems market and it is poised to grow by $255.58 mn during 2022-2026, accelerating at a CAGR of 5.26% during the forecast period. Our report on the femoral stems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of OA, osteoporosis, and RA, the increasing number of hip replacement surgeries, and advances in femoral stems.

The femoral stems market analysis includes type segment and geographic landscape.

Technavio's femoral stems market is segmented as below:

By Type

Cementless femoral stems
Cemented femoral stems

By Geographical Landscape

North America
Europe
Asia
Rest of the World (ROW)

This study identifies the increasing focus on robotic hip replacement surgeries as one of the prime reasons driving the femoral stem market growth during the next few years. Also, increasing demand for short stems among young patients and an increasing number of femoral stem replacement procedures will lead to sizable demand in the market.

Femoral stems market sizing
Femoral stems market forecast
Femoral stems market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading femoral stems market vendors that include Akcome Medical Holdings Co. Ltd., Altimed JSC, Amplitude SAS, B. Braun SE, Beijing Chunlizhengda Medical Instruments Co. Ltd., BEZNOSKA Sro, Biotechni SAS, Corentec Co. Ltd., EVOLUTIS SAS, Exactech Inc., GROUP FH ORTHO, Gruppo Bioimpianti Srl, IMECO SA, ImplanTec GmbH, Johnson and Johnson, Lepine Group, Limacorporate Spa, Medacta Group SA, Meril Life Sciences Pvt. Ltd., PETER BREHM GmbH, Smith and Nephew plc, Stryker Corp., X.NOV, and Zimmer Biomet Holdings Inc. Also, the femoral stems market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all future growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Product Code: IRTNTR74020

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Cementless femoral stems - Market size and forecast 2021-2026
Exhibit 28: Chart on Cementless femoral stems - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Cementless femoral stems - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Cementless femoral stems - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Cementless femoral stems - Year-over-year growth 2021-2026 (%)
5.4 Cemented femoral stems - Market size and forecast 2021-2026
Exhibit 32: Chart on Cemented femoral stems - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Cemented femoral stems - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Cemented femoral stems - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Cemented femoral stems - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Type
Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 France - Market size and forecast 2021-2026
Exhibit 66: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on France - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 Japan - Market size and forecast 2021-2026
Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Akcome Medical Holdings Co. Ltd.
Exhibit 85: Akcome Medical Holdings Co. Ltd. - Overview
Exhibit 86: Akcome Medical Holdings Co. Ltd. - Product / Service
Exhibit 87: Akcome Medical Holdings Co. Ltd. - Key offerings
10.4 Amplitude SAS
Exhibit 88: Amplitude SAS - Overview
Exhibit 89: Amplitude SAS - Business segments
Exhibit 90: Amplitude SAS - Key offerings
Exhibit 91: Amplitude SAS - Segment focus
10.5 B. Braun SE
Exhibit 92: B. Braun SE - Overview
Exhibit 93: B. Braun SE - Business segments
Exhibit 94: B. Braun SE - Key news
Exhibit 95: B. Braun SE - Key offerings
Exhibit 96: B. Braun SE - Segment focus
10.6 Beijing Chunlizhengda Medical Instruments Co. Ltd.
Exhibit 97: Beijing Chunlizhengda Medical Instruments Co. Ltd. - Overview
Exhibit 98: Beijing Chunlizhengda Medical Instruments Co. Ltd. - Product / Service
Exhibit 99: Beijing Chunlizhengda Medical Instruments Co. Ltd. - Key offerings
10.7 Biotechni SAS
Exhibit 100: Biotechni SAS - Overview
Exhibit 101: Biotechni SAS - Product / Service
Exhibit 102: Biotechni SAS - Key offerings
10.8 Corentec Co. Ltd.
Exhibit 103: Corentec Co. Ltd. - Overview
Exhibit 104: Corentec Co. Ltd. - Product / Service
Exhibit 105: Corentec Co. Ltd. - Key offerings
10.9 Johnson and Johnson
Exhibit 106: Johnson and Johnson - Overview
Exhibit 107: Johnson and Johnson - Business segments
Exhibit 108: Johnson and Johnson - Key news
Exhibit 109: Johnson and Johnson - Key offerings
Exhibit 110: Johnson and Johnson - Segment focus
10.10 Smith and Nephew plc
Exhibit 111: Smith and Nephew plc - Overview
Exhibit 112: Smith and Nephew plc - Business segments
Exhibit 113: Smith and Nephew plc - Key news
Exhibit 114: Smith and Nephew plc - Key offerings
Exhibit 115: Smith and Nephew plc - Segment focus
10.11 Stryker Corp.
Exhibit 116: Stryker Corp. - Overview
Exhibit 117: Stryker Corp. - Business segments
Exhibit 118: Stryker Corp. - Key news
Exhibit 119: Stryker Corp. - Key offerings
Exhibit 120: Stryker Corp. - Segment focus
10.12 Zimmer Biomet Holdings Inc.
Exhibit 121: Zimmer Biomet Holdings Inc. - Overview
Exhibit 122: Zimmer Biomet Holdings Inc. - Business segments
Exhibit 123: Zimmer Biomet Holdings Inc. - Key news
Exhibit 124: Zimmer Biomet Holdings Inc. - Key offerings
Exhibit 125: Zimmer Biomet Holdings Inc. - Segment focus

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 126: Inclusions checklist
Exhibit 127: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 128: Currency conversion rates for US$
11.4 Research methodology
Exhibit 129: Research methodology
Exhibit 130: Validation techniques employed for market sizing
Exhibit 131: Information sources
11.5 List of abbreviations
Exhibit 132: List of abbreviations